Structure-based optimization of Toddacoumalone as highly potent and selective PDE4 inhibitors with anti-inflammatory effects.

MLA

Zhou, Feng, et al. “Structure-Based Optimization of Toddacoumalone as Highly Potent and Selective PDE4 Inhibitors with Anti-Inflammatory Effects.” Biochemical Pharmacology, vol. 202, Aug. 2022, p. 115123. EBSCOhost, https://doi.org/10.1016/j.bcp.2022.115123.

APA

Zhou, F., Huang, Y., Liu, L., Song, Z., Hou, K.-Q., Yang, Y., Luo, H.-B., Huang, Y.-Y., & Xiong, X.-F. (2022). Structure-based optimization of Toddacoumalone as highly potent and selective PDE4 inhibitors with anti-inflammatory effects. Biochemical Pharmacology, 202, 115123. https://doi.org/10.1016/j.bcp.2022.115123

Chicago

Zhou, Feng, Yue Huang, Lu Liu, Zhendong Song, Ke-Qiang Hou, Yifan Yang, Hai-Bin Luo, Yi-You Huang, and Xiao-Feng Xiong. 2022. “Structure-Based Optimization of Toddacoumalone as Highly Potent and Selective PDE4 Inhibitors with Anti-Inflammatory Effects.” Biochemical Pharmacology 202 (August): 115123. doi:10.1016/j.bcp.2022.115123.